Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology

被引：0
|
作者：
Sankawa, Yuri
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [21] Pathological evaluation of tumor infiltrating lymphocytes and the benefit of nivolumab in advanced non-small cell lung cancer (NSCLC)
    Gataa, I.
    Mezquita, L.
    Auclin, E.
    Le Moulec, S.
    Alemany, P.
    Kossai, M.
    Masse, J.
    Caramella, C.
    Masip, J. Remon
    Lahmar, J.
    Ferrara, R.
    Gazzah, A.
    Soria, J-C.
    Planchard, D.
    Besse, B.
    Adam, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea.
    Park, Keunchil
    Cho, Eun Kyung
    Kang, Jin Hyoung
    Han, Ji-Youn
    Lee, Jong Seok
    Kim, Dong-Wan
    Kim, Sang-We
    Cho, Byoung Chul
    Min, Young Joo
    Lee, Ki Hyeong
    Kim, Joo-Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [23] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)
    Schmid-Bindert, Gerald
    TARGETED ONCOLOGY, 2013, 8 (01) : 15 - 26
  • [25] Brain metastases manifestaion of advanced non-small cell lung cancer (NSCLC)
    Koyi, H.
    Branden, E.
    Daham, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [26] Smoking and prognostic factors in advanced non-small cell lung cancer (NSCLC)
    Altug, S.
    Li, C.
    Marek, M.
    Guclu, S.
    Kim, Y.
    Meshref, M.
    Qin, S.
    Krejcy, K.
    Reece, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy for All?
    Hashemi-Sadraei, Nooshin
    Pennell, Nathan A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (04) : 478 - 490
  • [28] Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Tsiara, Anna
    Liontos, Michalis
    Kaparelou, Maria
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [29] Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Papachristos, A.
    Masinde, S.
    Davis, J. D.
    Gullo, G.
    Rietschel, P.
    Paccaly, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S309
  • [30] Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)
    Gerald Schmid-Bindert
    Targeted Oncology, 2013, 8 : 15 - 26
12345